Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

Bullboard (GREY:IVITF)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Comment by fmab011on Sep 30, 2019 1:39pm

RE:RE:RE:Q2 2019 numbers

Thank You Yowza 123. Much appreciated.
89
Discussion
Post by TheFixer5on Sep 30, 2019 1:14pm

Take over

I think i am at the point where i would love to see canopy or aphria buy this company.
252
Discussion
Comment by Yowza123on Sep 30, 2019 11:36am

RE:RE:Q2 2019 numbers

Regarding the German supply deal, here is some useful info: Originally the German deal was an LOI but  then the deal was solidified as per the following news release: https://www.newswire.ca/news ...more  
233
Discussion
Post by display_nameon Sep 30, 2019 10:34am

Shorters vs scalpers battle going on between tickers..

Matching blocks between tickers, looks to me like some parties shorting the price on OTC, then scalpters taking any OTC buys they they can flip across tickers for a profit after factoring in USD/CAD ...more  
143
Comment by fmab011on Sep 30, 2019 10:29am

RE:Q2 2019 numbers

This is NOT the first time Invictus has not issued at NR about quarterly financials. Trying to hide numbers on SEDAR is somewhat disturbing. Most transparent companies issue News Releases as ...more  
144
Discussion
Comment by gamos99on Sep 30, 2019 2:54am

RE:RE:RE:RE:Invictus revenues 415% over same quarter last year

$2.5M quarterly revenue is great but not happy about the big net loss. The cost of getting rid of Gene Simmosn and Canandia = $9 million ( I think you call these goodwill writedowns, i.e. the ...more  
209
Discussion
Post by gamos99on Sep 30, 2019 2:46am

Q2 2019 numbers

You'd think somebody here would actually take the time to post the quarter's numbers... here they are. GENE Q2 2019 Revenues:  $2.47M Expenses: ~$3 M Net earnings / loss: -$12.3 M ...more  
277
Discussion
Post by Yowza123on Sep 29, 2019 6:16pm

Short and Distort: Bear Market Stock Manipulation

https://www.investopedia.com/articles/analyst/030102.asp Watch out for these guys!!
117
Comment by Elstaunchoon Sep 29, 2019 12:29pm

RE:Bashers getting nervous

3rd quarter revenue should be a huge jump.  Started shipping out oil in August not to mention AB LABS now selling. Sounds very promising.
138
Discussion
Post by Yowza123on Sep 29, 2019 10:09am

Bashers getting nervous

I can tell the bashers are getting nervous as they are resorting to purely making stuff up. So many presumptions with no evidence. Do your own diligence. 
132
Discussion
Comment by Tigerwoods3672on Sep 29, 2019 1:07am

RE:RE:RE:RE:Invictus revenues 415% over same quarter last year

Man this is great stuff.  Thanks for the insight.  I dont even care anymore that ive got 8K gone up in smoke.  I want to see how this plays out now.  Have too big of a loss now to ...more  
190
Discussion
Comment by Yowza123on Sep 28, 2019 9:12pm

RE:RE:RE:RE:Invictus revenues 415% over same quarter last year

Show me where you get the information that Dixon gets 10X what he's worth. Or any real info on what he makes. Acreage and AB Labs are what's right with Invictus. Oooo they got a loan, cry me a ...more  
128
Discussion
Comment by M4DM4Xon Sep 28, 2019 5:11pm

RE:RE:RE:Invictus revenues 415% over same quarter last year

What was the point getting rid of that leech Gene Simmons, if you still have leeches like Dixon and his buddies paying themselves 10x what they're actually worth? For every dollar they're ...more  
187
Discussion
Comment by Yowza123on Sep 28, 2019 10:57am

RE:RE:RE:Invictus revenues 415% over same quarter last year

I realize the company has had a lot of negatives this past year but those who made the bad decisions are gone. The capacity of the company is about to triple very soon. With a little napkin math 2.5M ...more  
226
Discussion
Comment by Medinecheckon Sep 28, 2019 9:07am

RE:RE:Invictus revenues 415% over same quarter last year

revs 415 % up, sounds good for the first moment ! But... net loss doubled from 6 mill to 12 mill ! General expenses only down 200.000, equity loss up 120.000, and over 1.000.000 paid for bonuses, for ...more  
162
Discussion
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities